See All Slides - tctmd.com

Slides

Presentation Cell Therapy 2013

Myocardial Microtissue Injection in Chronic Ischemic Disease

Presenter: Steven A.J. Chamuleau

January 23, 2013

Presentation Cell Therapy 2013

Sitagliptin plus Granulocyte-Colony Stimulating Factor in Acute Myocardial Infarction

Presenter: Wolfgang-Michael Franz

January 22, 2013

Presentation Cell Therapy 2013

Adipose derived cells or chronic myocardial ischemia

Presenter: Francisco Fdez-Avil?s

January 22, 2013

Presentation Cell Therapy 2013

Clinical Outcomes and Surrogate Efficacy Data for a Phase II Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells (Revascor™) in Patients With Chronic Heart Failure of Ischemic or Nonischem

Presenter: Kenneth M. Borow

January 22, 2013

Presentation Cell Therapy 2013

A Phase 2 Pilot Study to Evaluate the Safety and Activity of BB3 as an Adjunct to PCI in Subjects Presenting with STEMI

Presenter: Frank J. Giordano

January 22, 2013

Presentation Cell Therapy 2013

IK 5001 - A Novel Approach to Myocardial Remodeling

Presenter: David F. Kong

January 22, 2013

Presentation Cell Therapy 2013

NOGA-Guided CD133+ Cells for CMI

Presenter: Wojciech Wojakowski

January 22, 2013

Presentation Cell Therapy 2013

Swiss AMI Study: Long-term Findings

Presenter: Daniel S?rder

January 22, 2013

Presentation Cell Therapy 2013

TIME: CCTRN Study of Bone Marrow-Derived Stem Cells Following STEMI

Presenter: Jay H. Traverse

January 22, 2013

Presentation Cell Therapy 2013

Cardiac-derived Stem Cells Post-MI: CADUCEUS and ALLSTAR

Presenter: Eduardo Marb?n

January 22, 2013

Advertisement

Slides

Myocardial Microtissue Injection in Chronic Ischemic Disease

Sitagliptin plus Granulocyte-Colony Stimulating Factor in Acute Myocardial Infarction

Adipose derived cells or chronic myocardial ischemia

Clinical Outcomes and Surrogate Efficacy Data for a Phase II Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells (Revascor™) in Patients With Chronic Heart Failure of Ischemic or Nonischem

A Phase 2 Pilot Study to Evaluate the Safety and Activity of BB3 as an Adjunct to PCI in Subjects Presenting with STEMI

IK 5001 - A Novel Approach to Myocardial Remodeling

NOGA-Guided CD133+ Cells for CMI

Swiss AMI Study: Long-term Findings

TIME: CCTRN Study of Bone Marrow-Derived Stem Cells Following STEMI

Cardiac-derived Stem Cells Post-MI: CADUCEUS and ALLSTAR

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content